Global Acne Clinical Trial Pipeline Highlights, 2019 - ResearchAndMarkets.com

DUBLIN--()--The "Global Acne Clinical Trial Pipeline Highlights, 2019" report has been added to ResearchAndMarkets.com's offering.

This report provides most up-to-date information on key pipeline products in the global Acne market. It covers emerging therapies for Acne in active clinical development stages including early and late stage clinical trials.

The pipeline data presented in this report helps executives in tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages

The report provides Acne pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes

The report provides Acne pipeline products by their dominant mechanism of action/drug class. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company

The report provides Acne pipeline products by the company.

Short-term Launch Highlights

Find out which Acne pipeline products will be launched in the US and Ex-US to 2024.

Summary

  1. Acne phase 3 clinical trial pipeline products
  2. Acne phase 2 clinical trial pipeline products
  3. Acne phase 1 clinical trial pipeline products
  4. Acne preclinical research pipeline products
  5. Acne discovery stage pipeline products
  6. Acne pipeline products short-term launch highlights

List of Tables

Table 1: Acne Phase 3 Clinical Trials, 2019

Table 2: Acne Phase 2 Clinical Trials, 2019

Table 3: Acne Phase 1 Clinical Trials, 2019

Table 4: Acne Preclinical Research, 2019

Table 5: Acne Discovery Stage, 2019

List of Figures

Figure 1: Acne Pipeline Molecules by Clinical Trials Stage, 2019

Figure 2: Acne Phase 3 Clinical Trial Highlights, 2019

Figure 3: Acne Phase 2 Clinical Trial Highlights, 2019

Figure 4: Acne Phase 1 Clinical Trial Highlights, 2019

Figure 5: Acne Preclinical Research Highlights, 2019

Figure 6: Acne Discovery Stage Highlights, 2019

For more information about this report visit https://www.researchandmarkets.com/r/9tb8qm

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Clinical Trials, Acne Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Clinical Trials, Acne Drugs